Cite
Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial.
MLA
De Winne, Koen, et al. “Immunohistochemistry as a Screening Tool for NTRK Gene Fusions: Results of a First Belgian Ring Trial.” Virchows Archiv: European Journal of Pathology, vol. 478, no. 2, Feb. 2021, pp. 283–91. EBSCOhost, https://doi.org/10.1007/s00428-020-02921-6.
APA
De Winne, K., Sorber, L., Lambin, S., Siozopoulou, V., Beniuga, G., Dedeurwaerdere, F., D’Haene, N., Habran, L., Libbrecht, L., Van Huysse, J., Weynand, B., Wouters, K., Pauwels, P., & Zwaenepoel, K. (2021). Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial. Virchows Archiv: European Journal of Pathology, 478(2), 283–291. https://doi.org/10.1007/s00428-020-02921-6
Chicago
De Winne, Koen, Laure Sorber, Suzan Lambin, Vasiliki Siozopoulou, Gabriela Beniuga, Franceska Dedeurwaerdere, Nicky D’Haene, et al. 2021. “Immunohistochemistry as a Screening Tool for NTRK Gene Fusions: Results of a First Belgian Ring Trial.” Virchows Archiv: European Journal of Pathology 478 (2): 283–91. doi:10.1007/s00428-020-02921-6.